Insmed Inc (INSM)vsBio-Techne Corp (TECH)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
TECH
Bio-Techne Corp
$52.69
+0.50%
HEALTHCARE · Cap: $8.20B
Smart Verdict
WallStSmart Research — data-driven comparison
Bio-Techne Corp generates 100% more annual revenue ($1.22B vs $606.42M). TECH leads profitability with a 6.7% profit margin vs -2.1%. TECH appears more attractively valued with a PEG of 0.66. TECH earns a higher WallStSmart Score of 48/100 (D+).
INSM
Hold39
out of 100
Grade: F
TECH
Hold48
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for INSM.
Margin of Safety
-460.5%
Fair Value
$11.32
Current Price
$52.69
$41.37 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Safe zone — low bankruptcy risk
Growing faster than its price suggests
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
ROE of 4.0% — below average capital efficiency
6.7% margin — thin
Weak financial health signals
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : TECH
The strongest argument for TECH centers on Altman Z-Score, PEG Ratio. PEG of 0.66 suggests the stock is reasonably priced for its growth.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : TECH
The primary concerns for TECH are Return on Equity, Profit Margin, Piotroski F-Score. A P/E of 98.9x leaves little room for execution misses.
Key Dynamics to Monitor
INSM profiles as a turnaround stock while TECH is a value play — different risk/reward profiles.
TECH carries more volatility with a beta of 1.48 — expect wider price swings.
INSM is growing revenue faster at 1.5% — sustainability is the question.
TECH generates stronger free cash flow (76M), providing more financial flexibility.
Bottom Line
TECH scores higher overall (48/100 vs 39/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Bio-Techne Corp
HEALTHCARE · BIOTECHNOLOGY · USA
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?